UBS ASSET MANAGEMENT AMERICAS LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 132 filers reported holding INTERSECT ENT INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$819,769,000
+111.4%
29,267
+106.1%
0.00%
Q4 2021$387,747,000
-44.2%
14,198
-44.4%
0.00%
Q3 2021$694,335,000
+66.4%
25,527
+4.6%
0.00%
Q2 2021$417,252,000
+38.8%
24,415
+69.6%
0.00%
Q1 2021$300,630,000
-8.8%
14,3980.0%0.00%
Q4 2020$329,714,000
+40.4%
14,3980.0%0.00%
Q3 2020$234,831,000
+20.5%
14,3980.0%0.00%
Q2 2020$194,949,000
+14.3%
14,3980.0%0.00%
Q1 2020$170,616,000
-73.5%
14,398
-44.3%
0.00%
Q4 2019$643,940,000
+212.9%
25,861
+113.7%
0.00%
Q3 2019$205,821,000
-27.8%
12,100
-3.4%
0.00%
Q2 2019$285,228,000
-54.9%
12,532
-36.3%
0.00%
Q1 2019$632,744,000
+88.2%
19,681
+64.9%
0.00%
Q4 2018$336,244,000
-2.0%
11,9320.0%0.00%
Q3 2018$343,045,000
-23.2%
11,9320.0%0.00%
Q2 2018$446,853,000
+43.3%
11,932
+50.4%
0.00%
Q1 2018$311,728,000
+29.5%
7,932
+6.7%
0.00%
Q4 2017$240,797,000
+10.4%
7,432
+6.2%
0.00%
Q3 2017$218,050,000
+3268.1%
7,000
-98.3%
0.00%
-100.0%
Q3 2016$6,474,000
+18.5%
408,717
-3.2%
0.01%
+16.7%
Q2 2016$5,461,000
+6.7%
422,368
+56.8%
0.01%0.0%
Q1 2016$5,117,000
-16.9%
269,340
-1.6%
0.01%
-14.3%
Q4 2015$6,160,000
-12.2%
273,791
-8.7%
0.01%
-12.5%
Q3 2015$7,018,000
-9.4%
299,946
+10.9%
0.01%
+14.3%
Q2 2015$7,743,000270,4720.01%
Other shareholders
INTERSECT ENT INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,332,773$27,828,0005.75%
First Light Asset Management, LLC 2,036,645$42,525,0002.82%
Altium Capital Management LP 141,856$2,962,0000.82%
PURA VIDA INVESTMENTS, LLC 909,660$18,994,0000.54%
Rock Springs Capital Management LP 1,080,200$22,555,0000.49%
Novo Holdings A/S 508,922$10,626,0000.44%
Davide Leone & Partners Investment Co Ltd. 109,240$2,281,0000.28%
PURA VIDA INVESTMENTS, LLC 256,800$5,362,0000.15%
Bellevue Group AG 617,968$12,903,0000.14%
Gyon Technologies Capital Management, LP 13,318$278,0000.12%
View complete list of INTERSECT ENT INC shareholders